Poland· PL-100100276
Viramune
A nevirapine product containing nevirapinum, registered in Poland by Boehringer Ingelheim International GmbH. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Nevirapine is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AG01 (nevirapine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Nevirapine · ATC J05AG01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nevirapine costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $3.81 in France to $7.77 in Switzerland — a ×2.0 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nevirapine · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$7.77
- FR France$3.81
The record
At a glance
URPL (Poland)- Active substance
- Nevirapinum
- Manufacturer
- Boehringer Ingelheim International GmbH
- Country
- Poland (PL)
- ATC code
- J05AG01
- ATC class
- Nevirapine
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991508623
- gtin05909990861712
- gtin05909991513085
- gtin09006968005065
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
316 interactions on record for nevirapine.
Graded by severity as the source publishes them — 26 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nevirapine · interactions on record
316 records
- 26 severe
- 220 moderate
- 8 minor
- 49 info
Most severe, free to view
- DeflazacortH02AB13severe
- BrigatinibL01ED04severe
- LorlatinibL01ED05severe
- CobimetinibL01EE02severe
13 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nevirapine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayNevirapine aurobindoAurobindo
- SpainVIRAMUNE 50 mg/5 ml SUSPENSION ORALBoehringer Ingelheim International Gmbh
- FinlandViramuneBoehringer Ingelheim International GmbH
- FranceVIRAMUNE 50 mg/5 ml, suspension buvableBOEHRINGER INGELHEIM INTERNATIONAL
- IcelandViramuneBoehringer Ingelheim International GmbH*
- NetherlandsViramune 50 mg/5 ml Oral Suspension, suspensie voor oraal gebruikBoehringer Ingelheim Pharma GmbH & Co. KG
- BelgiumViramune 50 mg/5 mlBoehringer Ingelheim International
- SwedenViramune 50 mg/5 ml Oral suspensionBoehringer Ingelheim International GmbH
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Nevirapin Viatris
- Belgium · Nevirapine Viatris
- Germany · Nevirapin Abdi, Nevirapin Aurobindo
- Denmark · Nevirapine Medical Valley, Nevirapine Viatris
- Spain · Nevirapina Aurovitas, Nevirapina Kern Pharma
- Finland · Nevirapine Viatris
- France · Nevirapine Arrow Lab, Nevirapine Cristers
- United Kingdom (Northern Ireland) · Nevirapine Accord, Nevirapine Accord Healthcare
- Greece · Nevirapine Vocate
- Iceland · Viramune
- Italy · Nevirapina Aurobindo, Nevirapina Mylan
- Liechtenstein · Viramune
- Luxembourg · Nevirapine Viatris
- Netherlands · Nevirapine Accord, Nevirapine Amarox
- Norway · Viramune
- Portugal · Nevirapina Accord, Nevirapina Aurovitas
- Romania · Nevirapina Accord, Nevirapină Accord
- Sweden · Nevirapine Medical Valley
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9ab7813e-e9a4-46ac-8239-4bb3c56fbde6 GET /v1/drugs/9ab7813e-e9a4-46ac-8239-4bb3c56fbde6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina doustna",
"source": "urpl",
"strength": "50 mg/5 ml",
"packaging": "05909990861712 ¦ Rpz ¦ Skasowane ¦ EU/1/97/055/002 ¦ 17185\n1 butelka 240 ml ¦ 1 strzykawka 5 ml\n05909991508623 ¦ Rpz ¦ Skasowane ¦ EU/1/97/055/010 ¦ 149108\n1 butelka 240 ml\n05909991513085 ¦ Rpz ¦ EU/1/97/055/002 ¦ 149869\n1 strzykawka 5 ml + 1 łącznik ¦ 1 butelka 240 ml\n¦ UR/Z/4c/036/25 - 09006968005065",
"substance": "Nevirapinum 10 mg",
"common_name": "Nevirapinum",
"pl_product_id": "100100276",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about nevirapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.